Ectopic fat and adipokines in metabolically benign overweight/obese women: The kronos early estrogen prevention study

Obesity

Volumn 21, Issue 8, 2013, Pages 1726-1733

  Ogorodnikova, Alexandra D ^a   Khan, Unab I ^a   McGinn, Aileen P ^a   Zeb, Irfan ^b   Budoff, Matthew J ^b   Harman, S M ^c   Miller, Virginia M ^d   Brinton, Eliot A ^e   Manson, Joann E ^f   Hodis, Howard N ^g   Merriam, George R ^h   Cedars, Marcelle I ⁱ   Taylor, Hugh S ^j   Naftolin, Frederick ^k   Lobo, Rogerio A ^l   Santoro, Nanette ^m   Wildman, Rachel P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c Kronos Longevity Research Institute   (United States)

^d MAYO CLINIC   (United States)

^e Utah Foundation for Biomedical Research   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Columbia University College of Medicine ^*  (United States)

^m UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CONJUGATED ESTROGEN; ESTRADIOL; GLUCOSE; HIGH MOLECULAR WEIGHT ADIPONECTIN; LEPTIN; LEPTIN RECEPTOR; PROGESTERONE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; EPICARDIUM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KRONOS EARLY ESTROGEN PREVENTION STUDY; LIVER; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; METABOLICALLY BENIGN OBESITY; OBESITY; PERICARDIUM; RISK ASSESSMENT; SMOKING; TYPES OF STUDY; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSE TISSUE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEPTIN; LIFE STYLE; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; PERICARDIUM; POSTMENOPAUSE; PROSPECTIVE STUDIES; RECEPTORS, LEPTIN;

EID: 84883161989     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20200     Document Type: Article

References (38)

1. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB,. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-1872.
2. Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S,. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007; 100: 1654-1658.
3. Marini MA, Succurro E, Frontoni S, et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 2007; 30: 2145-2147.
4. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617-1624.
5. Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004; 109: 706-713.
6. Katzmarzyk PT, Janssen I, Ross R, et al. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006; 29: 404-409.
7. Flint AJ, Hu FB, Glynn RJ, et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) 2010; 18: 377-383.
8. Ogorodnikova AD, Kim M, McGinn AP, Muntner P, Khan U, Wildman RP,. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring) 2012; 20: 651-659.
9. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86: 1020-1025.
10. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609-1616.
11. Messier V, Karelis AD, Robillard ME, et al. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism 2010; 59: 20-24.
12. Aguilar-Salinas CA, Garcia EG, Robles L, et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 2008; 93: 4075-4079.
13. Labruna G, Pasanisi F, Nardelli C, et al. High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients. Obesity (Silver Spring) 2011; 19: 1492-1496.
14. Khan UI, Ogorodnikova AD, Xu L, et al. The adipokine profile of metabolically benign obese and at-risk normal weight postmenopausal women: the women's health initiative observational study. Obesity (Silver Spring) 2012.
15. Miller VM, Black DM, Brinton EA, et al. Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res 2009; 2: 228-239.
16. Zeb I, Li D, Nasir K, Katz R, Larijani VN, Budoff MJ,. Computed tomography scans in the evaluation of Fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 2012; 19: 811-818.
17. Skurk T, Alberti-Huber C, Herder C, Hauner H,. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007; 92: 1023-1033.
18. Huang G, Wang D, Zeb I, et al. Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis 2012; 221: 198-205.
19. Chan JL, Bluher S, Yiannakouris N, Suchard MA, Kratzsch J, Mantzoros CS,. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 2002; 51: 2105-2112.
20. Hamaguchi M, Kojima T, Takeda N, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13: 1579-1584.
21. Targher G, Bertolini L, Poli F, et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005; 54: 3541-3546.
22. Iacobellis G, Sharma AM, Pellicelli AM, Grisorio B, Barbarini G, Barbaro G,. Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome. Curr HIV Res 2007; 5: 275-279.
23. Taguchi R, Takasu J, Itani Y, et al. Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 2001; 157: 203-209.
24. Yudkin JS, Eringa E, Stehouwer CD,. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005; 365: 1817-1820.
25. Ding J, Kritchevsky SB, Harris TB, et al. The association of pericardial fat with calcified coronary plaque. Obesity (Silver Spring) 2008; 16: 1914-1919.
26. Rabkin SW,. Epicardial fat: properties, function and relationship to obesity. Obes Rev 2007; 8: 253-261.
27. Ahmadi N, Nabavi V, Yang E, et al. Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium. Acad Radiol 2010; 17: 1518-1524.
28. Mahabadi AA, Massaro JM, Rosito GA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009; 30: 850-856.
29. Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117: 605-613.
30. Huang G, Wang D, Zeb I, et al. Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis 2011; 221: 198-205.
31. Sicari R, Sironi AM, Petz R, et al. Pericardial Rather Than Epicardial Fat is a Cardiometabolic Risk Marker: An MRI vs Echo Study. J Am Soc Echocardiogr 2011; 24: 1156-1162.
32. Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005; 48: 634-642.
33. Ceddia RB, William WN, Jr., Curi R,. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation. Int J Obes Relat Metab Disord 1999; 23: 75-82.
34. Meier U, Gressner AM,. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
35. Li WC, Hsiao KY, Chen IC, Chang YC, Wang SH, Wu KH,. Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults. Cardiovasc Diabetol 2011; 10: 36.
36. Goldstein BJ, Scalia R,. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-2568.
37. You T, Ryan AS, Nicklas BJ,. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004; 89: 5517-5522.
38. Khan UI, Wang D, Thurston RC, et al. Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN). Atherosclerosis 2011; 217: 179-186.